Variable uterine uptake of FDG in adenomyosis during concurrent chemoradiation therapy for cervical cancer.
10.3857/roj.2011.29.3.214
- Author:
Jeong Il YU
1
;
Seung Jae HUH
;
Young Il KIM
;
Tae Joong KIM
;
Byung Kwan PARK
Author Information
1. Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea. sj5201.huh@samsung.com
- Publication Type:Case Report
- Keywords:
Positron emission tomography/computed tomography;
Concurrent chemoradiation therapy;
Adenomyosis
- MeSH:
Adenomyosis;
Adult;
Endometrium;
Female;
Humans;
Menstrual Cycle;
Positron-Emission Tomography;
Tumor Burden;
Uterine Cervical Neoplasms
- From:Radiation Oncology Journal
2011;29(3):214-217
- CountryRepublic of Korea
- Language:English
-
Abstract:
To avoid improper tumor volume contouring in radiation therapy (RT) and other invasive procedures, we report a case of uterine adenomyosis showing increased 18F-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET)/computed tomography (CT) mimicking malignant tumor in a 44-year-old woman during concurrent chemoradiation therapy (CCRT) for uterine cervical cancer. The adenomyosis was not associated with her menstrual cycle or with normal endometrium uptake, and it resolved one month after completion of RT. This case indicates that uterine adenomyosis in a premenopausal woman may show false positive uptake of 18FDG-PET/CT associated with CCRT.
